73 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
RDY Dr. Reddy's Laboratories Ltd $35.7 $5.93B N/A
Article Searches
Sanofi's (SNY) LixiLan Positive in Phase III Diabetes Study http://www.zacks.com/stock/news/189981/sanofis-sny-lixilan-positive-in-phase-iii-diabetes-study?cid=CS-ZC-FT-189981 Sep 14, 2015 - Sanofi (SNY) reported positive top-line data from the second of two pivotal phase III studies (LixiLan-L) on type II diabetes candidate, LixiLan.
Relypsa (RLYP) Looks Good: Stock Rises 8% http://www.zacks.com/stock/news/189717/relypsa-rlyp-adds-8-in-session?cid=CS-ZC-FT-189717 Sep 11, 2015 - Relypsa, Inc. (RLYP) was a big mover last session, as the company saw its shares rise almost 8% on the day.
Cymabay Therapeutics (CBAY) Looks Good: Stock Up 7.2% http://www.zacks.com/stock/news/190670/cymabay-therapeutics-inc-cbay-saw-its-shares-rise-over-7-on-the-day?cid=CS-ZC-FT-190670 Sep 21, 2015 - Cymabay Therapeutics, Inc. (CBAY) was a big mover last session, as the company saw its shares rise over 7% on the day.
AxoGen (AXGN) Looks Good: Stock Adds 13.8% in Session http://www.zacks.com/stock/news/190203/axogen-inc-axgn-saw-its-shares-rise-almost-14-on-the-day?cid=CS-ZC-FT-190203 Sep 16, 2015 - AxoGen, Inc. (AXGN) was a big mover last session, as the company saw its shares rise almost 14% on the day.
Dr. Reddy's Laboratories' (RDY) CFO Saumen Chakraborty on Q2 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3620746-dr-reddys-laboratories-rdy-cfo-saumen-chakraborty-on-q2-2016-results-earnings-call-transcript?source=feed_tag_india Oct 29, 2015 - Dr. Reddy's Laboratories Limited (NYSE:RDY) Q2 2016 Earnings Conference Call October 29, 2015, 09:00 AM EDT Executives Kedar Upadhye - Head of Global Generics Finance & Investor Relations Saumen C
Dr. Reddy's Laboratories' (RDY) Management Discusses on Q3 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3879876-dr-reddys-laboratories-rdy-management-discusses-q3-2016-results-earnings-call-transcript?source=feed_tag_india Feb 09, 2016 - Dr. Reddy's Laboratories Limited (NYSE:RDY) Q3 2016 Earnings Conference Call February 9, 2016 8:00 AM ET Executives Kedar Upadhye – Investor Relations Saumen Chakraborty – Chief Financial Officer Abhi
Dr. Reddy's (RDY) Q1 Earnings and Revenues Decline Y/Y http://www.zacks.com/stock/news/225226/dr-reddys-rdy-q1-earnings-and-revenues-decline-y-y?cid=CS-ZC-FT-225226 Jul 27, 2016 - Dr. Reddy's (RDY) reported first-quarter fiscal 2017 earnings per American Depositary Share of 11 cents, down 79.6% from the year-ago quarter.
New Strong Sell Stocks for July 28th http://www.zacks.com/stock/news/225559/new-strong-sell-stocks-for-july-28th?cid=CS-ZC-FT-225559 Jul 28, 2016 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
Sucampo (SCMP) Beats Q4 Earnings, 2017 View Reaffirmed http://www.zacks.com/stock/news/252292/sucampo-scmp-beats-q4-earnings-2017-view-reaffirmed?cid=CS-ZC-FT-252292 Mar 09, 2017 - Sucampo Pharmaceuticals, Inc. (SCMP) reported adjusted earnings of 68 cents per share in the fourth quarter of 2016, beating the Zacks Consensus Estimate of 49 cents by 38.8%.
Mylan Down on FDA Warning Letter to Manufacturing Facility http://www.zacks.com/stock/news/256244/mylan-down-on-fda-warning-letter-to-manufacturing-facility?cid=CS-ZC-FT-256244 Apr 12, 2017 - Shares of Mylan, Inc. (MYL) dropped 2% after the company received a warning letter from the FDA for its manufacturing facility in India

Pages: 12345678

<<<Page 3>